COMPANY NAME	REVENUES 12 Months Ending Q4 2022	MARKET SHARE 12 Months Q4 2022	MARKET SHARE MRQ Q4 2022	MARKET SHARE A Quarter Before Q3 2022
Jounce Therapeutics inc	147.87	82.64%	0.00 %	0.00 %
Surface Oncology Inc	31.06	17.36%	0.00%	0.00%

JNCE's Market share relative to its competitors, as of Q4 2022 within the Biotechnology & Pharmaceuticals Industry

As of Q4 2022

COMPANY NAME	MARKET SHARE 12 Months Ending Q4 2022	MARKET SHARE 12 Months Ending Q3 2022	MARKET SHARE MRQ Q4 2022	MARKET SHARE Q3 2022
Jounce Therapeutics inc	82.64%	82.64%	100.00 %	0.00 %
Surface Oncology Inc	17.36%	17.36%	0.00%	0.00%

JNCE's Market share relative to its competitors, as of Q4 2022 within the Healthcare Sector

As of Q4 2022

COMPANY NAME	MARKET SHARE 12 Months Ending Q4 2022	MARKET SHARE 12 Months Ending Q3 2022	MARKET SHARE MRQ Q4 2022	MARKET SHARE Q3 2022
Jounce Therapeutics inc	82.64%	82.64%	100.00 %	0.00 %
Surface Oncology Inc	17.36%	17.36%	0.00%	0.00%

Note: Market share is calculated based on total revenue. To get a more accurate picture of Jounce Therapeutics inc's market divisions, geographic dispersion, segments, products, and services, visit Jounce Therapeutics inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.